CAAS Capital Management’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-30,000
Closed -$363K 1400
2021
Q1
$363K Buy
+30,000
New +$595K ﹤0.01% 982

Other funds holding LHDX

CAAS Capital Management's LHDX Position: Q2 2021 in Review

CAAS Capital Management sold out of Lucira Health, Inc. Common Stock (LHDX) in Q2 2021, closing a stake of 30,000 shares — an estimated $363K sold.

CAAS Capital Management first reported a position in LHDX in Q1 2021 and held it in 1 quarter. The position peaked at $363K in Q1 2021. 44 funds tracked by Wall St. Rank hold LHDX as of Q2 2021.

  • CAAS Capital Management reported no remaining Lucira Health, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • CAAS Capital Management sold 30,000 Lucira Health, Inc. Common Stock shares in Q2 2021, an estimated $363K.
  • CAAS Capital Management first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • CAAS Capital Management's Lucira Health, Inc. Common Stock position peaked at $363K in Q1 2021.
  • 44 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q2 2021.

Based on CAAS Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.